S. Corsello

发表

Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.

S. Corsello, S. Casa, L. Marinis, 1989, The Journal of clinical endocrinology and metabolism.

Paroxystic hypertension in a long-term hemodialyzed patient. Successful adrenalectomy for a dopamine-producing pheochromocytoma

R. Bellantone, L. Tazza, F. Crucitti, 1995, Journal of endocrinological investigation.

Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: A retrospective study

A. Pontecorvi, G. Papi, S. Corsello, 2009, Journal of endocrinological investigation.

Intracranial and spinal dissemination of an ACTH secreting pituitary neoplasia. Case report and review of the literature.

C. Anile, S. Della Casa, P. Putignano, 1997, Annales d'endocrinologie.

Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.

A. Tofani, R. Sciuto, S. Della Casa, 1992, Metabolism: clinical and experimental.

Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle.

A. Tofani, S. Della Casa, A. Barini, 1989, Metabolism: clinical and experimental.

Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.

E. Menis, F. Trimarchi, S. Cannavò, 2003, European journal of endocrinology.

Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer.

M. Mandalà, S. Casa, C. Barone, 1998, European journal of endocrinology.

Acute complications in the course of “mild” hyperparathyroidism

A. Tofani, F. Crucitti, A. Barbarino, 1991, Journal of endocrinological investigation.

Incidentally discovered adrenal masses: a functional and morphological study.

V. Rufini, L. Troncone, L. Bollanti, 2009, Experimental and clinical endocrinology.

Giant prolactinomas in men: efficacy of cabergoline treatment

S. Corsello, C. A. Rota, M. Altomare, 2003, Clinical endocrinology.

Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.

A. Tofani, R. Sciuto, L. Bollanti, 1990, The Journal of clinical endocrinology and metabolism.

Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry

S. Cannavò, M. Losa, C. Scaroni, 2015, Clinical endocrinology.

Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)

S. Cannavò, M. Losa, C. Scaroni, 2018, Journal of Endocrinological Investigation.

Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.

A. Tofani, R. Sciuto, S. Della Casa, 1991, The Journal of clinical endocrinology and metabolism.

The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.

A. Grossman, P. Bouloux, M. Besser, 1996, British journal of clinical pharmacology.

The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel

A. Pontecorvi, A. Bianchi, F. Lugli, 2011, Journal of endocrinological investigation.

Dexamethasone inhibition of interferon-alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome.

S. Della Casa, A. Barini, A. Barbarino, 1995, The Journal of clinical endocrinology and metabolism.